Patents Assigned to N30 PHARMACEUTICALS, LLC
  • Publication number: 20120295966
    Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
    Type: Application
    Filed: February 12, 2010
    Publication date: November 22, 2012
    Applicant: N30 PHARMACEUTICALS, LLC
    Inventors: Xicheng Sun, Jian Qiu, Jan Wasley
  • Publication number: 20120289555
    Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
    Type: Application
    Filed: February 10, 2011
    Publication date: November 15, 2012
    Applicant: N30 PHARMACEUTICALS, LLC
    Inventors: Xicheng Sun, Jian Qiu
  • Publication number: 20120245210
    Abstract: The present invention is directed to novel thiophene inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
    Type: Application
    Filed: December 14, 2010
    Publication date: September 27, 2012
    Applicant: N30 PHARMACEUTICALS, LLC
    Inventor: Xicheng Sun
  • Publication number: 20120208817
    Abstract: The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
    Type: Application
    Filed: September 24, 2010
    Publication date: August 16, 2012
    Applicant: N30 PHARMACEUTICALS, LLC
    Inventors: Xicheng Sun, Jian Qiu
  • Publication number: 20110144110
    Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
    Type: Application
    Filed: August 14, 2009
    Publication date: June 16, 2011
    Applicant: N30 PHARMACEUTICALS, LLC
    Inventors: Jan Wasley, Gary J. Rosenthal, Xicheng Sun, Sarah Strong, Jian Qiu
  • Publication number: 20110144180
    Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
    Type: Application
    Filed: August 14, 2009
    Publication date: June 16, 2011
    Applicant: N30 PHARMACEUTICALS, LLC
    Inventors: Jan Wasley, Gary J. Rosenthal, Xicheng Sun, Sarah Strong, Jian Qiu
  • Publication number: 20110136875
    Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
    Type: Application
    Filed: August 14, 2009
    Publication date: June 9, 2011
    Applicant: N30 PHARMACEUTICALS, LLC
    Inventors: Jan Wasley, Gary J. Rosenthal, Xicheng Sun, Sarah Strong, Jian Qiu
  • Publication number: 20110136881
    Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
    Type: Application
    Filed: August 14, 2009
    Publication date: June 9, 2011
    Applicant: N30 PHARMACEUTICALS, LLC
    Inventors: Jan Wasley, Gary J. Rosenthal, Xicheng Sun, Sarah Strong, Jian Qiu